Demand Forecast
Drill-down by category, sub-category, or SKU (p50 + p95 model)
SKU · AUC3700216205899
Oméga 3 Marins GPH – Équilibre Cardiaque & Cerveau – 100 Capsules
longtail
3P
COMPLEMENTS ALIMENTAIRES - THE INFUSION
Last 4 weeks demand
14
▼ 54.8% vs prev 4w
Offer Stock
242
Σ Stock across 2 live offers (1P + 3P) · 2026-10-02
1P stock
0
no 1P (MARJANEMALL) stock in the 2026-10-02 snapshot
Unit price
MAD 156
avg of last 30 sells · latest 2026-09-26
AUC3700216205899
History (last 52 weeks) and LightGBM p95-quantile forecast for the SKU.
Cutoff: 2026-09-28 · Total forecast: 140 units.
Actual
Realistic forecast (p50)
Optimistic
Out of stock
Price history
Weekly qty-weighted average (MAD) of every non-null price/cost column in the OrderBook for this SKU. Click a legend entry to hide/show a line.
Why this forecast?
Oméga 3 Marins GPH – Équilibre Cardiaque & Cerveau – 100 Capsules · in the longtail cohort · last 4 weeks 14 units, trending down -54.8% · on-hand 120 units
Signals the model saw
- Cohort: longtail (1064 days of history, 354 units sold over 52 weeks)
- Volatility (CV): 0.87 — moderate
- Recent trend: last 4w = 14 units · prev 4w = 31 units
- Stockouts (last 13 weeks): none — history is reliable
- Calendar events firing in forecast window: none
Model output
| Realistic forecast — next week | 1.4 units |
| Realistic forecast — next 4 weeks | 6.0 units |
| Realistic forecast — next 3 months | 45.1 units |
| Planning level (p75) — next 4 weeks the order-sizing basis; demand exceeds it ~1 week in 4 | 15.5 units |
| Optimistic — next week | 9.1 units |
| Optimistic — next 4 weeks (reorder target) | 45.8 units |
| Optimistic — next 3 months (quarterly PO target) | 140.2 units |
| Legacy μ/wk (reorder pipeline) | 4.3 |
| Revenue exposure — optimistic, 3 months | MAD 21.9K |